tongjitang prices us share sale below range
Tongjitang Chinese Medicines has priced its United States share sale at about 30 per cent below the bottom end of the initial range. The company's three shareholders raised a lower than expected US$98.7 million, pricing 9.87 million American depositary receipts at US$10 each, sources said. Bloomberg
ubs turns bullish on yangzijiang shipbuilding
Yangzijiang Shipbuilding (Holdings) may deliver 38 per cent annual profit growth until 2009, according to a UBS report. Revenue was expected to jump 58 per cent annually during the period, bolstered by the completion of a shipyard this year and a full order book into 2010, the report said. Bloomberg
lending to mainland rises
Hong Kong's lending to mainland firms and individuals reached HK$545.7 billion at the end of last year, up 1.9 per cent from the third quarter, the Hong Kong Monetary Authority's latest data showed.
